Genetic mutation in esophageal cancer found to have dual effects

FHS
January 3, 2025
11:36 am

A genetic fault long believed to drive the development of esophageal cancer may in fact play a protective role early in the disease, according to new research published in Nature Cancer.

Abridge Raises $250M to Advance AI-Powered Clinical Documentation

What You Should Know: – Abridge, a provider of generative AI solutions for healthcare, today announced a $250M Series D funding round, bringing its total

February 18, 2025

Brexanolone by Sage Therapeutics for Alcohol Dependence: Likelihood of Approval

Brexanolone is under clinical development by Sage Therapeutics and currently in Phase I for Alcohol Dependence.

February 9, 2024

Lonza expands capsule footprint; BioCentriq’s new HQ

Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and more. Lonza is Sign up to read

December 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.